Ipca Laboratories has remained a consistent performer over the last few quarters .Ipca Laboratories posted good traction in the pain/analgesics segment (up 39% year-on-year or y-o-y) and gastro (up 36% y-o-y) segment, according to analysts' data
The text above is a summary, you can read full article here.